WAT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Waters Corp (WAT) does not present a compelling buy opportunity for a beginner investor with a long-term perspective at this time. While there are some positive catalysts such as recent product launches and a few optimistic analyst ratings, the mixed financial performance, lack of strong trading signals, and hedge fund selling trends suggest caution. The current pre-market price of $319.5 is near the analyst consensus price targets, leaving limited upside potential.
The MACD histogram is positive at 3.715, indicating bullish momentum, but it is contracting. RSI is neutral at 54.362, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong directional trend. Key resistance is at $330.176, and support is at $299.356.
Recent product launch of omniDAWN™ Multi-Angle Light Scattering Photometer, which could enhance laboratory efficiency.
Goldman Sachs reinstated coverage with a Buy rating and a $375 price target, citing one-time headwinds and an attractive entry point.
Evercore ISI upgraded the stock to Outperform, expecting achievable Q1 numbers and a second-half ramp.
Hedge funds are selling, with a 125.80% increase in selling activity last quarter.
Mixed financial performance in Q4 2025, with net income and EPS declining YoY despite revenue growth.
Analysts' price targets have been revised downward by multiple firms, reflecting cautious sentiment.
No recent congressional trading data or strong insider buying trends to support confidence.
In Q4 2025, revenue increased by 6.83% YoY to $932.36M, but net income dropped by 2.67% YoY to $225.21M. EPS also declined by 2.84% YoY to $3.76. Gross margin improved slightly to 59.79%, up 1.82% YoY. Overall, financial performance shows mixed results with growth in revenue but declining profitability.
Analyst sentiment is mixed. Goldman Sachs and Citi have Buy ratings with price targets of $375 and $425, respectively, citing one-time headwinds and potential synergies. However, UBS, Deutsche Bank, and Morgan Stanley have Neutral or Hold ratings with price targets around $330, reflecting cautious optimism. The consensus suggests limited upside from the current price.
